ArticleAnnals of hematology2026
Regional brain iron deposition and functional alterations in thalassemia: a multimodal human study with murine validation.
Article in Annals of hematology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
BACKGROUND AND
objectivesChronic anemia and systemic iron overload in thalassemia major (TM) patients may result in neurological deficits, although researchers have not completely elucidated their specific impacts on the brain. This study employed a multimodal research methodology to investigate the characteristics and intrinsic connections of cerebral iron deposition, cerebral dysfunction, and cognitive impairment in TM patients, providing theoretical support for brain monitoring and neuroprotective interventions in this condition.
methodsWe prospectively enrolled 88 patients with TM, including 46 transfusion-dependent thalassemia (TDT) and 42 non-transfusion-dependent thalassemia (NTDT) patients, alongside 79 healthy controls (HCs), between September 2022 and September 2025. All participants underwent quantitative susceptibility mapping (QSM), resting-state functional MRI (rs-fMRI), and assessments using the Mini-Mental State Examination (MMSE) and the Montreal Cognitive Assessment (MoCA). Serum biomarkers including S100 calcium-binding protein B (S100B) and neuron-specific enolase (NSE) were quantified. A parallel murine model of iron overload was created for validation purposes.
resultsQSM revealed localised iron deposition in the red nucleus, substantia nigra, subthalamic nucleus, and globus pallidus of patients with TM (F = 3.294-13.305, P = 0.001-0.040). The susceptibility values in these basal ganglia regions demonstrated a negative link with cognitive scores (r = - 0.27 to - 0.43, P < 0.05), suggesting that localised iron buildup correlates with cognitive decline.Rs-fMRI revealed significant irregularities in spontaneous brain activity across the frontal lobe-limbic system-cerebellar network, which correlated with deficits in attention, memory, and language functions as assessed by the cognitive evaluation scale. A murine iron overload model further demonstrated that cerebral iron deposition originates in the choroid plexus.Serum S100B and NSE concentrations increased progressively from HCs to NTDT and TDT groups (P < 0.05), reflecting gradual loss of astrocytic and neuronal integrity driven by worsening systemic iron overload.
conclusionsTM patients, especially those with TDT, exhibit measurable cognitive impairment and cerebral functional remodeling, which are tightly associated with regional brain iron deposition. This study's findings establish a theoretical foundation for the early detection of thalassemia-associated neurological problems and the formulation of focused therapeutic strategies.
Indexed as
Identifiers
42911382What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.